AN1 Stock Overview
Engages in the health wellness and beauty business. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Anagenics Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.008 |
52 Week High | AU$0.021 |
52 Week Low | AU$0.006 |
Beta | -1.01 |
11 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | -57.89% |
33 Year Change | -85.71% |
5 Year Change | -96.98% |
Change since IPO | -99.79% |
Recent News & Updates
Recent updates
Shareholder Returns
AN1 | AU Personal Products | AU Market | |
---|---|---|---|
7D | 0% | -7.6% | 0.9% |
1Y | -57.9% | 54.1% | 18.4% |
Return vs Industry: AN1 underperformed the Australian Personal Products industry which returned 54.1% over the past year.
Return vs Market: AN1 underperformed the Australian Market which returned 18.4% over the past year.
Price Volatility
AN1 volatility | |
---|---|
AN1 Average Weekly Movement | n/a |
Personal Products Industry Average Movement | 5.6% |
Market Average Movement | 8.6% |
10% most volatile stocks in AU Market | 17.3% |
10% least volatile stocks in AU Market | 3.3% |
Stable Share Price: AN1's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: Insufficient data to determine AN1's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2004 | n/a | n/a | anagenics.com |
Anagenics Limited engages in the health wellness and beauty business. The company develops, manufactures, and markets anti-ageing hair care products under the évolis brand; and skin, hair, and body care products under the Uspa brand name. It also imports and distributes skin care and wellbeing products to spas, clinics, salons, retail stores, and online in Australia, New Zealand, and the Pacific Islands.
Anagenics Limited Fundamentals Summary
AN1 fundamental statistics | |
---|---|
Market cap | AU$3.69m |
Earnings (TTM) | -AU$7.28m |
Revenue (TTM) | AU$10.80m |
0.3x
P/S Ratio-0.5x
P/E RatioIs AN1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AN1 income statement (TTM) | |
---|---|
Revenue | AU$10.80m |
Cost of Revenue | AU$6.44m |
Gross Profit | AU$4.36m |
Other Expenses | AU$11.65m |
Earnings | -AU$7.28m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.016 |
Gross Margin | 40.37% |
Net Profit Margin | -67.43% |
Debt/Equity Ratio | 10.0% |
How did AN1 perform over the long term?
See historical performance and comparison